"10.1371_journal.pone.0111764","plos one","2014-12-04T00:00:00Z","Anna G Frostegård; Jun Su; Xiang Hua; Max Vikström; Ulf de Faire; Johan Frostegård","Institute of Environmental Medicine, Unit of Immunology and Chronic Disease, Karolinska Institutet, Stockholm, Sweden; Institute of Environmental Medicine, Unit of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden; Department of Acute Internal Medicine, Huddinge, Karolinska University Hospital, Stockholm, Sweden","Conceived and designed the experiments: AF UdF JF. Performed the experiments: XH JS. Analyzed the data: MV AF JF JS. Contributed reagents/materials/analysis tools: JF UdF. Wrote the paper: AF JF.","JF and UdF are named as inventors on patents/pending relating to anti-PC antibodies only (as indicated below). Anti-PC diagnostic patents: (1) METHOD of DIAGNOSTING CARDIOVASCULAR DISEASE AND EARLY ATHEROSCLEROSIS PCT/SE1999/001208, EP999334, inventor: FROSTEGÅRD Johan (SE), Anti-PC therapeutic patents family; and (2) METHOD OF ASSESSING THE RISK OF ISCHEMIC CARDIOVASCULAR DISEASE USING PHOSPHORYLCHOLINE CONJUGATES US 8012483, inventors: FROSTEGÅRD Johan (SE), De FAIRE Ulf (SE), granted 2008. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","12","Anna G Frostegård","AGF",6,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
